Press Releases

Mar 20 2018
AmpliPhi Biosciences Announces Registered Direct Offering of Common Stock
Mar 19 2018
AmpliPhi to Collaborate with Western Sydney Local Health District and Westmead Institute for Medical Research on Expanded Access for Investigational Bacteriophage Therapeutics AB-SA01 and AB-PA01
Mar 14 2018
AmpliPhi Biosciences Reports Fourth Quarter and Full Year 2017 Financial Results and Business Highlights
Mar 13 2018
AmpliPhi to Collaborate with the U.S. Department of Veterans Affairs on Expanded Access for Investigational Bacteriophage Therapeutics AB-SA01 and AB-PA01
Mar 09 2018
AmpliPhi Biosciences Announces Presentation of Preclinical Data Demonstrating that AB-PA01 Reduces Biofilm in Pseudomonas aeruginosa In Vivo Model
Jan 10 2018
AmpliPhi Biosciences Announces Pricing of $4.0 Million Public Offering of Common Stock
Jan 09 2018
AmpliPhi Biosciences Announces Proposed Public Offering of Common Stock
Jan 03 2018
AmpliPhi Biosciences Announces Positive Interim Results for Single-Patient Expanded Access Program Utilizing AB-SA01 and AB-PA01
Jan 02 2018
AmpliPhi Biosciences to Present at Biotech Showcase 2018
Dec 14 2017
AmpliPhi Biosciences Provides Corporate and Strategic Update

Business Wire InvestorHQ^sm